Nanostructured lipid carriers: Promising drug delivery systems for future clinics.

By A. Beloqui, M. Solinís, A. Rodríguez-Gascón, A. Almeida, V. Préat. Nanomedicine: Nanotechnology, Biology and Medicine, 2016

615 citations recorded by the source corpus.

Subfields: Molecular Biology, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/031396e6302eb7879fcc761fa77f445f096b277a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. S. Mohammadi-Samani
2. Parisa Ghasemiyeh

In Pharmaceutical Science

1. S. Mohammadi-Samani
2. Parisa Ghasemiyeh

Citations in the corpus

• Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages (2018, positive): “NLCs are second generation of lipid-based nanocarriers formed from mixture of solid and liquid lipids and have unstructured-matrix due to the different moieties of the constituents of NLCs (2).”
• Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies (2021, background): “They reported that Compritol TM 888 ATO was the safest lipid owing to its neutral cytotoxic effect (Brugè et al. 2015).”